Concepedia
Statistics
Publications
5
Citations
185
H-Index
Active since
2004
Affiliations
The University of Tokyo(Current)
Chugai Pharma (United States)
Kiyotaka Nakano is an author at The University of Tokyo specializing in mutation, oncology, and cell signaling.
Publications per year
2004–2025
Anti-glypican 3 antibodies cause ADCC against human hepatocellular carcinoma cells
Kiyotaka Nakano, Tetsuro Orita, Jun‐ichi Nezu et al. · Biochemical and Biophysical Research Communications · 2008 · 111 citations
Medicine, Oncology, Pharmacology +14
Novel heat shock protein HspQ stimulates the degradation of mutant DnaA protein in <i>Escherichia coli</i>
Toh‐ru Shimuta, Kiyotaka Nakano, Yoko Yamaguchi et al. · Genes to Cells · 2004 · 29 citations · Full text
Life Sciences, Genetics, Molecular Biology +15
DGC-specific<i>RHOA</i>mutations maintained cancer cell survival and promoted cell migration via ROCK inactivation
Takashi Nishizawa, Kiyotaka Nakano, Aya Harada et al. · Oncotarget · 2018 · 20 citations · Full text
Life Sciences, Cell Biology, Oncology +17
Robust and reproducible human intestinal organoid-derived monolayer model for analyzing drug absorption
Kai Tanaka, Tatsuki Mochizuki, Shogo Baba et al. · Scientific Reports · 2025 · 13 citations · Full text
Pharmacy, Pharmacokinetics, Pharmacology +17
βARK1 Inhibition Improves Survival in a Mouse Model of Heart Failure Induced by Myocardial Infarction
Yoshiyuki Suzuki, Kiyotaka Nakano, Masakazu Sugiyama et al. · Journal of Cardiovascular Pharmacology · 2004 · 12 citations
Medicine, Cardiology, Molecular Biology +15
1–5 of 5